Skip to main content
Erschienen in: Cardiovascular Diabetology 1/2022

Open Access 01.12.2022 | Research

Insulin resistance phenotype is associated with vascular risk phenotype at the end of the second decade of life: a population-based study

verfasst von: Janaina Maiana Abreu Barbosa, Antônio Augusto Moura da Silva, Rosangela Fernandes Lucena Batista, Bernadete Jorge Leal Salgado, Joelma Ximenes Prado Teixeira Nascimento, Vanda Maria Ferreira Simões, Maria Jacqueline Silva Ribeiro, Marco Antonio Barbieri, Alexandre Archanjo Ferraro, Cecilia Claudia Costa Ribeiro

Erschienen in: Cardiovascular Diabetology | Ausgabe 1/2022

Abstract

We hypothesize that early events of diabetes and cardiovascular disease continuums would be ongoing and associated in adolescents. We investigated the association between the Insulin Resistance Phenotype and the Vascular Risk Phenotype at the end of the second decade of life and indirect pathways from social vulnerability, alcohol consumption, and body fat mass. It is a population-based study in the RPS cohort of 18–19 years (n = 2,515), São Luís, Brazil. The theoretical model analyzed the association between Insulin Resistance Phenotype and Vascular Risk Phenotype by sex, using structural equation modeling (SEM). The Insulin Resistance Phenotype was a latent variable deduced from the correlations of Triglyceride to HDL ratio, Triglyceride Glycemic index, and VLDL; the Vascular Risk Phenotype was deduced from Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Wave Velocity. The Insulin Resistance Phenotype was directly associated with the Vascular Risk Phenotype in males (standardized coefficient SC = 0.183; p < 0.001) and females (SC = 0.152; p < 0.001). The Insulin Resistance Phenotype was an indirect pathway in the association of alcohol consumption and higher values of fat mass index with the Vascular Risk Phenotype. VLDL presented the highest factor loading, appearing as a marker of insulin resistance linked to cardiovascular risk in young people. Lower values of socioeconomic status, harmful use of alcohol, and high body fat values were also associated with higher values of the two phenotypes. The association of the Insulin Resistance Phenotype with the Vascular Risk Phenotype suggests common pathophysiological mechanisms present in early events in the continuums of diabetes and cardiovascular disease in adolescence.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
MACE
Major adverse cardiac event
CVD
Cardiovascular diseases
VLDL
Very-Low-Density lipoprotein
TG/HDL
Triglyceride to HDL ratio
TyG
Triglyceride glycemic index
SBP
Systolic blood pressure
DBP
Diastolic blood pressure
PWV
Carotid-Femoral pulse wave velocity
SINASC
Brazilian live birth information system
AUDIT
Alcohol use disorders identification test
DEXA
Dual-energy x-ray absorptiometry
TG
Triglycerides
HDL
High-Density lipoprotein
SEM
Structural equation modeling
CFA
Confirmatory factor analysis
RMSEA
Root mean square error of approximation
CFI
Comparative fit index
TLI
Tucker-Lewis index
WLSMV
Weighted least square mean and variance adjusted
SC
Standardized coefficient

Introduction

Cardiovascular severe events such as coronary artery disease, heart failure, and myocardial infarction known as Major Adverse Cardiac Event (MACE) manifest in adults [1]. Decades earlier, in the MACE latency period, the cardiovascular continuum is already ongoing, a chain of earlier pathophysiological events involving oxidative stress, inflammatory responses, endothelial dysfunction and atherosclerosis [2].
Type 2 diabetes also has the continuum characteristic, involving oxidative stress and inflammatory response, which progressively cause changes in insulin signaling pathways, changes in glucose transport and pancreatic beta-cell dysfunction until the clinical diagnosis of the disease [3]. Type 2 diabetes is a recognized risk factor for Cardiovascular Diseases (CVD) [4].
However, even before hyperglycemia installation, excess fatty acids in the pancreas, liver and heart increase insulin secretion and hepatic glucose production, resulting in diastolic dysfunction [5]. In the liver, the release of free fatty acids results in hyperinsulinemia and hypertriglyceridemia by de novo lipogenesis [6] and Very-Low-Density Lipoprotein (VLDL) secretion [7]. The increase in triglycerides also results in inflammation and endothelial dysfunction, turning into the ideal environment for atherogenesis, even before type 2 diabetes installation [8].
Thus, dyslipidemia and visceral obesity seem implicated in the genesis of diabetes and CVD [9], with involvement of vascular inflammation and early endothelial dysfunction [10]. We hypothesize that early events of diabetes and cardiovascular continuums would be ongoing and already associated in adolescence, a sensitive period for human development.
We propose the latent variable Insulin Resistance Phenotype representing early Type 2 Diabetes continuum events. This Phenotype was deduced from the shared variance of the indicators Triglyceride to HDL ratio (TG/HDL), Triglyceride Glycemic Index (TyG) and VLDL levels. None of these isolated indicators measure the Insulin Resistance Phenotype well; however, using them together as a continuous latent variable may reduce the error magnitude of measuring insulin resistance in adolescents. At the same time, the Vascular Risk Phenotype represents the shared variance between Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) and Carotid-Femoral Pulse Wave Velocity (PWV) to assess incipient vascular alterations in young people [11].
In this study, we investigated the association between the Insulin Resistance Phenotype and the Vascular Risk Phenotype at the end of the second decade of life, using a model that considered the complexity of this relationship and adjustments for social determinants, alcohol consumption and body fat mass in young people.

Methods

Study design

A population-based study was nested within the RPS cohort of 18–19 years (n = 2,515), São Luís, Brazil, from January to November 2016.
All individuals who participated at the beginning of the original cohort were invited to participate in the second follow-up (n = 687). The cohort follow-up also included other individuals born in São Luís, Brazil, in 1997 by drawing from the Brazilian Live Birth Information System (SINASC) (n = 1,133) to increase the sample's power and prevent future losses (retrospective cohort). The second stage included volunteers identified in schools and universities registered at SINASC and born in 1997 (n = 695). Thus, the sample of this study consisted of 2,515 adolescents (Fig. 1).

Data collection

We collected information from the adolescents: sex, education of the adolescent and the head of household, socioeconomic class, monthly family income, consumption of alcoholic beverages, fat mass index, TG/HDL ratio, TyG index, VLDL levels, SBP, DBP and PWV.
The following indicators were included in the latent variable socioeconomic status: (1) Household head´s education (elementary, secondary and higher education), (2) Adolescent´s education (elementary, secondary and higher education); (3) Socioeconomic class (A, B, C, D-E) using the CCEB criteria of the Brazilian Economic Classification, in which Class A is the wealthiest/most educated; and (4) Monthly household income based on the Brazilian national minimum wage in force in 2016 (USD 270.76). Alcohol consumption was assessed using the Alcohol Use Disorders Identification Test (AUDIT) questionnaire from the World Health Organization and classified as low and high risk.
Fat mass was calculated by dual-energy x-ray absorptiometry (DEXA), and height was measured with a stadiometer (Altura Exata®). The fat mass index was used as a body fat parameter, corresponding to the fat mass (kg) divided by the square of the body height (m2) and used as a continuous variable.
For blood collection, 40 Ml was obtained from the cubital vein before the snack was served to the adolescents who were fasting for at least 2 hrs to assess triglycerides (TG) (mg/dL), High-Density Lipoprotein (HDL) (mg/dL), blood glucose (mg/dL) and VLDL (mg/dL) contents. These markers were analyzed using the Sysmex XE-2100® hematology analyzer.
The TG/HDL ratio has been used as a metabolic marker of insulin resistance [12]. The TyG index is a marker of insulin resistance more accessible to clinical practice than the insulin resistance index (HOMA-IR). TyG was calculated by multiplying blood glucose by triglycerides, as in formula: Ln [Triglyceride (mg/dL) x fasting glucose (mg/dL)/2], where Ln is the Naperian logarithm [13]. The VLDL concentration, which has high concentrations of triglycerides, is also used as a marker of insulin resistance in adolescents [14]. All the indicators of insulin resistance were used as continuous variables.
Blood pressure was measured with the oscillometric method using the OMRON HEM-742INT® automated cuff device (Omron, São Paulo, Brazil). Three measurements were taken after at least 5 min at rest with a 1 min interval, in a sitting position, with the dominant arm supported at the heart level. The mean of three values represented the adolescent´s blood pressure in the analysis.

Latent variables

This study used as latent variables:
1)
Family Socioeconomic Status deduced from the shared variance of the indicators household head´s education, education of the adolescent, socioeconomic class according to CEB criteria and family monthly income;
 
2)
Insulin Resistance Phenotype deduced from the shared variance of TG-HDL ratio, TyG index and VLDL concentration;
 
3)
Vascular Risk Phenotype deduced from the shared variance of SBP, DBP and PWV.
 

Proposed theoretical model

The latent Family Socioeconomic Status was considered the most distal determinant and would explain all other variables in the model. Harmful use of alcohol would be associated with fat mass index, Insulin Resistance Phenotype and Vascular Risk Phenotype. The fat mass index would be associated with the Insulin Resistance Phenotype and the Vascular Risk Phenotype. The Insulin Resistance Phenotype would be related to the Vascular Risk Phenotype (Fig. 2).

Statistical analysis

Descriptive data were analyzed using the STATA® statistical software, version 16.0. Absolute and relative frequencies described categorical variables. Females and males were tested in separate models, using Structural Equation Modeling (SEM). SEM performs confirmatory factor analysis and estimates a series of multiple regression equations. The main function is the specification and estimation of models of linear relationships between variables observed (effect indicators) or latent (constructed). Latent variables are constructs derived from the combination of observed ones, extracting the common variance shared by these effect indicators. A latent variable estimates effect free from bias originating from measurement errors. This approach is of the utmost relevance to the Insulin Resistance Phenotype and the Vascular Risk Phenotype assessments since no effect indicators alone would be reasonable for measuring these phenotypes in adolescents. Factor loadings above 0.50 were adopted as criteria for evaluating convergent validity in Confirmatory Factor Analysis (CFA) for the latent variables which tested whether the theoretical factor structure was adequate for the observed data. Parameters of Root Mean Square Error of Approximation (RMSEA) were adopted with the upper limit of 90% confidence interval below 0.08 and CFI (Comparative Fit Index) and TLI (Tucker-Lewis Index) > 0.95. The Weighted Least Square Mean and Variance Adjusted (WLSMV) estimator and theta parameterization were used in the SEM to determine whether the data fitted the theoretical model, considering the same estimates described for CFA [15] using the software Mplus 8.0®.

Results

The study included 2,515 adolescents aged between 18 and 19 years, 52.5% (n = 1,319) were female, 69.9% (n = 1,758) had completed high school, 50.2% (n = 1,116) belonged to socioeconomic class C, and 43.1% (n = 1,085) from a family with income of 1 and  < 2 monthly minimum wages. Regarding the household head´s education, 59.3% (n = 1,339) had completed high school. Harmful use of alcohol was identified in 19.4% (n = 489) of participants (Table 1). The mean fat mass index was 6.38 kg/m2 (SD ± 3.07), TG-HDL ratio was 2.05 (SD ± 1.72), TyG index was 8.22 (SD ± 0.46), VLDL concentration was 18.13 mg/dL (SD ± 9.43), SBP value was 113.91 mmHg (SD ± 12.13), DBP value was 70.69 mmHg (SD ± 7.30), and PWV  value was 5.50 m/s (SD ± 0.88).
Table 1
Socioeconomic characteristics and alcohol consumption of adolescents in São Luís, Brazil (2022)
Variable
n
%
Sex
 Male
1196
47.5
 Female
1319
52.5
Adolescent’s education
 Elementary school
83
3.3
 High school
1758
69.9
 University education
672
26.8
Household head’s education
 Elementary School
593
26.3
 High school
1339
59.3
 University education
325
14.4
*CEB
 A
94
4.2
 B
566
25.4
 C
1116
50.2
 D/E
450
20.2
Household income
 ≤1 MW
802
31.9
 1–2 MW
1085
43.1
 3–4 MW
341
13.6
 ≥5 MW
287
11.4
Alcohol
 Low risk
2026
80.6
 High risk
489
19.4
*Brazil economic classification
Minimum wage (R$ 880.00)
The male and female models showed reasonable fit rates (Table 2). All indicators of the latent variables Family Socioeconomic Status, Insulin Resistance Phenotype and Vascular Risk Phenotype showed good convergent validity with factor loadings above 0.5 for both sexes. VLDL was the indicator with the highest factor loading in males (standardized coefficient CP = 0.990; p < 0.001) and in females (CP = 0.969; p < 0.001), that accounted for almost all of the latent Resistance to Insulin (Table 3).
Table 2
Fit indices in the structural equation models for association between insulin resistance phenotype and vascular risk phenotype in adolescents. São Luís, Brazil (2022)
Model fit index
Expected index
Found index
Found index
Male
Female
*X2
 
240.869
342.131
Degrees of freedom
 
132
132
P value X2
 
 < 0.0001
 < 0.0001
RMSEA
<0.06
0.058
0.058
90% CI
 < 0.08
0.054–0.063
0.054–0.063
C§FI
 > 0.95
0.979
0.979
||TLI
 > 0.95
0.974
0.974
*Chi-square test
Root mean square error of approximation
Confidence interval
§|Comparative fit index
||Tucker Lewis index
Table 3
Factor loading, standard error and p-values of the latent variables indicators: family socioeconomic status, insulin resistance phenotype and vascular risk phenotype. São Luís, Brazil (2022)
Latent variable
Male
Female
Standardized coefficient
Standard error
P-value
Standardized coefficient
Standard error
P-value
*Family socioeconomic status
 Household head’s education
0.646
0.023
 < 0.001
0.641
0.022
 < 0.001
 Socioeconomic class
0.853
0.025
 < 0.001
0.894
0.022
 < 0.001
 Adolescent’s education
0.534
0.027
 < 0.001
0.566
0.027
 < 0.001
 Monthly income
0.499
0.023
 < 0.001
0.533
0.022
 < 0.001
Insulin resistance phenotype
 TG-HDL ratio
0.860
0.007
 < 0.001
0.774
0.003
 < 0.001
 VLDL
0.990
0.006
 < 0.001
0.969
0.003
 < 0.001
 TyG
0.940
0.011
 < 0.001
0.800
0.005
 < 0.001
Vascular risk phenotype
 SBP
0.737
0.016
 < 0.001
0.825
0.015
 < 0.001
 DBP
0.672
0.015
 < 0.001
0.723
0.012
 < 0.001
 PWV
0.530
0.015
 < 0.001
0.618
0.016
 < 0.001
*Family socioeconomic status: latent variable defined by the household head´s education, socioeconomic class according to CEB criteria, adolescent´s education, and monthly household income; Insulin Resistance Phenotype: defined by the Triglyceride to HDL ratio (TG-HDL), VLDL and Triglyceride Glycemic Index (TyG) ratio. Vascular Risk Phenotype: Systolic Blood Pressure (SBP); Diastolic Blood Pressure (DBP), and Carotid-Femoral Pulse Wave Velocity (PWV)
The Insulin Resistance Phenotype was associated with the Vascular Risk Phenotype in males (CP = 0.183; p < 0.001) and in females (CP = 0.152; p < 0.001). In addition, the Insulin Resistance Phenotype was an indirect pathway for the association between harmful use of alcohol and the Vascular Risk Phenotype in males (CP = 0.020; p = 0.006) and in females (CP = 0.014; p = 0.039). The Insulin Resistance Phenotype was also an indirect pathway for the association of higher values of fat mass index and Vascular Risk Phenotype in males (CP = 0.054; p < 0.001) and in females (CP = 0.041; p < 0.001) (Fig. 2).
As secondary findings, higher values of Socioeconomic Status were associated with lower values of Insulin Resistance Phenotype in males (CP = −0.081; p = 0.028) and in females (CP = −0.126; p < 0.001). Family Socioeconomic Status was also associated with lower values of the Vascular Risk Phenotype, but only in females (CP = −0.157; p < 0.001), while higher values of Family Socioeconomic Status were associated with higher values of male fat mass index (CP = 0.229; p < 0.001). Harmful use of alcohol was associated with the Insulin Resistance Phenotype in males (CP = 0.112; p = 0.001) and in females (CP = 0.092; p = 0.036). Higher values of fat mass index were also associated with the Insulin Resistance Phenotype in males (CP = 0.296; p < 0.001) and in females (CP = 0.273; p < 0.001), and it was also directly associated with higher values of the Vascular Risk Phenotype in males (CP = 0.191; p < 0.001) and in females (CP = 0.296; p < 0.001) (Fig. 2).

Discussion

Our findings add to the evidence that early events of continuums of diabetes and cardiovascular disease are already present in adolescents, showing an association between the Insulin Resistance Phenotype and the Vascular Risk Phenotype in both sexes. The Insulin Resistance Phenotype was also an indirect association pathway between higher values of fat mass index and the Vascular Risk Phenotype. Harmful use of alcohol was directly associated with the Insulin Resistance Phenotype and indirectly associated with the Vascular Risk Phenotype through the pathway of increased values of the Insulin Resistance Phenotype.
The Insulin Resistance Phenotype showed high convergent validity (standardized coefficient SC > 0.7) for the indicators TG-HDL ratio, TyG index and VLDL concentrations in both sexes. The increase in triglycerides is the crucial event in the alteration of insulin sensitivity, already observed in white adipose tissue [16] and the liver [6]. The TG-HDL ratio has been identified as an early marker of insulin resistance, capable of predicting Type 2 Diabetes [17]. Furthermore, the TG-HDL ratio is more efficient than HOMA-IR for diagnosing insulin resistance in obese young people [18]. The TyG index is also a marker of insulin resistance based on the increase in the flow of free fatty acids from adipose tissue to the liver and increase in hepatic triglycerides, which are strong determinants of hepatic insulin resistance [13]. Concurrently, hepatic synthesis of triglycerides results in increased production of VLDL cholesterol [7].
All indicators (SBP, DBP and PWV) of the latent variable Vascular Risk Phenotype had convergent validity for both sexes. These results confirm previous findings; however, using a population-based sample that was 3.85 times larger than our anterior study (n = 653) [11]. Advantageously, the Vascular Risk Phenotype represents incipient vascular alterations linked to vascular risk in young people while not requiring the adoption of a cut-off point to address vascular risk in this population.
Higher values of fat mass index were directly associated with the Insulin Resistance Phenotype. This phenotype was an indirect pathway in the association between higher values of fat mass index with the Vascular Risk Phenotype. The increase in adipocytes results in hypoxia and consequently the accumulation of macrophages in adipose tissue, which is the primary source of inflammatory mediators that can induce insulin resistance [19]. Oxidative stress in obesity can culminate in mitochondrial dysfunction and consequently lipid accumulation, accelerating both insulin resistance [20] and atherosclerosis [21]. Insulin resistance has been explained from the lipocentric view. The collection of intramuscular lipids from the entry of fatty acids into cells inhibits the translocation of GLUT-4 to the plasma membrane, leading to the loss of insulin-dependent glucose uptake [22].
Higher values of fat mass index were also directly associated with the Vascular Risk Phenotype, which could be due to excess fat, leading to increased blood pressure via elevated sympathetic activity, subsequent sodium reabsorption, and peripheral vascular resistance [23].
The Insulin Resistance Phenotype and the Vascular Risk Phenotype were also directly associated. As a possible explanation, excessive dietary carbohydrate intake induces insulin resistance in skeletal muscle, which can promote atherogenic dyslipidemia by diverting carbohydrates used in muscle glycogen storage to de novo lipogenesis (Fig. 2), resulting in elevated plasma triglyceride, decreased HDL, elevated small and dense LDL and reduced hepatic triglyceride synthesis, and consequently, increasing VLDL [24]. Added sugars activate hepatic lipogenesis pathways from glucose [25] and fructose [26] by increasing plasma triglyceride levels and result in dyslipidemia [27], insulin resistance [28] and type 2 diabetes [29] regardless of fat. Fructose induces the faster formation of fatty acids compared to glucose since it lacks hepatic feedback regulatory mechanisms [30], increasing de novo lipogenesis and liver fat, decreasing insulin sensitivity, regardless of weight gain [31], contributing to the greater secretion of VLDL [32].
VLDL was the indicator of the Insulin Resistance Phenotype showing the highest factor loading in both sexes, emerging in our study as an insulin resistance marker linked to cardiovascular risk in young people. Research using VLDL as a biological marker is scarcer, even though VLDL is associated with insulin resistance [14] and CVD [33]. Elevated plasma triglyceride and VLDL determine greater insulin secretion in obese adolescents, regardless of initial insulin sensitivity [14]. Insulin resistance plays an essential role in VLDL metabolism by increasing the availability of apolipoprotein B (ApoB), the primary lipoprotein of VLDL, leading to the increased hepatic synthesis of VLDL [34]. At the same time, VLDL concentration is essential in the initiation and progression of atherosclerosis [33] and can manifest in young people [35].
Harmful use of alcohol was directly associated with the Insulin Resistance Phenotype. In addition, the harmful use of alcohol in young people was indirectly associated with the Vascular Risk Phenotype through increased Insulin Resistance Phenotype in both sexes. Excessive alcohol consumption is linked to oxidative stress, inflammatory responses [36] and hypertension [37].
More distally, higher values of Family Socioeconomic Status were associated with lower values of the Insulin Resistance Phenotype in both sexes. Higher values of Family Socioeconomic Status were also associated with lower values of the Vascular Risk Phenotype, but only in females, confirming a previous study that shows the highest cardiovascular risk and incredibly high disease burden for low-income groups [38]. Low socioeconomic status groups have a higher risk of developing cardiovascular disease [39]. People with lower socioeconomic status may be more vulnerable to CVD and diabetes due to material deprivation, unsanitary living conditions, limited access to high-quality health care, reduced opportunities to prevent complications, inappropriate, risky behavior such as tobacco use, unhealthy foods habits, a sedentary lifestyle and being overweight or obese [40]. A possible explanation for this difference between the sexes in our study is that higher values of Family Socioeconomic Status were associated with higher values of fat mass index in boys. In addition, cardiovascular risk is also higher for males [41], which could be explained by hormonal differences, possibly linked to estrogen activities or factors associated with the X chromosome that protect vascular walls in females [42].
The main limitation is that the cross-sectional design did not allow us to assume a temporal link among the exploratory variables, Insulin Resistance Phenotype, and the vascular outcome. Furthermore, we cannot rule out reverse causality in shown associations, for example, the inverse pathway of the Insulin Resistance Phenotype increasing the fat mass index. Some bias may arise from losing participants from the original Cohort from birth and the necessity to open the sample at 18–19 follow-up to survey representativeness. In this respect, to guarantee the sample power fellow was opened using official Brazilian data (SINASC). In this respect, we compared some characteristics between the original cohort and new participants from SINASC (retrospective cohort) related to head of the family, economic class, monthly family income, alcohol consumption, and fat mass index; however, we did not find statistically significant differences between these populations.
The study’s strengths lie in the construction of the latent variable Insulin Resistance Phenotype aimed at reducing the measurement error of early markers of insulin resistance and test the validity of the Vascular Risk Phenotype in a population sample stratified by sex to estimate incipient vascular changes in adolescents.

Conclusions

The contribution of this study has been to estimate the association between early events of diabetes and cardiovascular continuums through both the Insulin Resistance Phenotype and Vascular Risk Phenotype. Lower values of socioeconomic status, harmful use of alcohol, and higher values of body fat were also associated with the two phenotypes. The association of Insulin Resistance Phenotype with Vascular Risk Phenotype in young people suggests common pathophysiological mechanisms in diabetes and cardiovascular continuums.

Acknowledgements

The authors thank the financial support from the Brazilian Ministry of Health/Department of Science and Technology (DECIT), Maranhão State Research Foundation for Scientific and Technological Development (FAPEMA), São Paulo State Research Foundation (FAPESP), National Council for Scientific and Technological Development (CNPq), and Coordination for the Improvement of Higher Education Personnel (CAPES) Finance Code 001.

Declarations

This study was approved by the Ethics and Research Committee of the University Hospital—UFMA (opinion number: 1,302,489). All participants in the research signed the Free and Informed Consent Form.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Lin FJ, Tseng WK, Yin WH, et al. Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus. Sci Rep. 2017;7:1–9. Lin FJ, Tseng WK, Yin WH, et al. Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus. Sci Rep. 2017;7:1–9.
2.
Zurück zum Zitat Dzau VJ, Antman EM, Black HR, et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation. 2006;114:2850–70.CrossRef Dzau VJ, Antman EM, Black HR, et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation. 2006;114:2850–70.CrossRef
3.
Zurück zum Zitat Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414:799–806.CrossRef Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414:799–806.CrossRef
4.
Zurück zum Zitat Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–22.CrossRef Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–22.CrossRef
5.
Zurück zum Zitat Hollingsworth KG, Al-Mrabeh A, Steven S, et al. Pancreatic triacylglycerol distribution in type 2 diabetes. Diabetologia. 2015;58:2676–8.CrossRef Hollingsworth KG, Al-Mrabeh A, Steven S, et al. Pancreatic triacylglycerol distribution in type 2 diabetes. Diabetologia. 2015;58:2676–8.CrossRef
6.
Zurück zum Zitat Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125–31.CrossRef Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125–31.CrossRef
7.
Zurück zum Zitat Lewis GF, Steiner G. Acute effects of insulin in the control of VLDL production in humans: implications for the insulinresistant state. Diabetes Care. 1996;19:390–3.CrossRef Lewis GF, Steiner G. Acute effects of insulin in the control of VLDL production in humans: implications for the insulinresistant state. Diabetes Care. 1996;19:390–3.CrossRef
8.
Zurück zum Zitat Précoma DB, Oliveira GMM. Update of the cardiovascular prevention guideline of the Brazilian society of cardiology—2019. Arq Bras Cardiol. 2019;113:787–891. Précoma DB, Oliveira GMM. Update of the cardiovascular prevention guideline of the Brazilian society of cardiology—2019. Arq Bras Cardiol. 2019;113:787–891.
9.
Zurück zum Zitat Hsueh WA, Lei RE. Cardiovascular risk continuum: implications of insulin resistance and diabetes. Am J Med. 1998;105:4–14.CrossRef Hsueh WA, Lei RE. Cardiovascular risk continuum: implications of insulin resistance and diabetes. Am J Med. 1998;105:4–14.CrossRef
10.
Zurück zum Zitat Ryder E, Pedreañez A, Vargas R, et al. Increased proinflammatory markers and lipoperoxidation in obese individuals: inicial inflammatory events? Diabetes Metab Syndr. 2015;9:280–6.CrossRef Ryder E, Pedreañez A, Vargas R, et al. Increased proinflammatory markers and lipoperoxidation in obese individuals: inicial inflammatory events? Diabetes Metab Syndr. 2015;9:280–6.CrossRef
11.
Zurück zum Zitat Amaral MS, Ribeiro CCC, Alves MTSBE, et al. Modeling pathways from the perinatal factors to the vascular risk phenotype at the end of the second decade of life birth cohort, Brazil. Hypertension. 2020;76:359–65.CrossRef Amaral MS, Ribeiro CCC, Alves MTSBE, et al. Modeling pathways from the perinatal factors to the vascular risk phenotype at the end of the second decade of life birth cohort, Brazil. Hypertension. 2020;76:359–65.CrossRef
12.
Zurück zum Zitat Lin D, Qi Y, Huang C, et al. Associations of lipid parameters with insulin resistance and diabetes: a population-based study. Clin Nutr. 2018;37:1423–9.CrossRef Lin D, Qi Y, Huang C, et al. Associations of lipid parameters with insulin resistance and diabetes: a population-based study. Clin Nutr. 2018;37:1423–9.CrossRef
13.
Zurück zum Zitat Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299–304.CrossRef Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299–304.CrossRef
14.
Zurück zum Zitat Tricò D, Natali A, Mari A, et al. Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents. Diabetes Obes Metab. 2018;20:2905–10.CrossRef Tricò D, Natali A, Mari A, et al. Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents. Diabetes Obes Metab. 2018;20:2905–10.CrossRef
15.
Zurück zum Zitat Byrne BM. Structural equation modeling with Mplus: basic concepts, applications and programming. New York: Routledge; 2012. Byrne BM. Structural equation modeling with Mplus: basic concepts, applications and programming. New York: Routledge; 2012.
16.
Zurück zum Zitat Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrin. 2013;218:25–36.CrossRef Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrin. 2013;218:25–36.CrossRef
17.
Zurück zum Zitat Iwani NA, Jalaludin MY, Zin RM, et al. Triglyceride to HDL-C ratio is associated with insulin resistance in overweight and obese children. Sci Rep. 2017;7:1–7.CrossRef Iwani NA, Jalaludin MY, Zin RM, et al. Triglyceride to HDL-C ratio is associated with insulin resistance in overweight and obese children. Sci Rep. 2017;7:1–7.CrossRef
18.
Zurück zum Zitat Liang J, Fu J, Jiang Y, et al. Triglycerides and high-density lipoprotein cholesterol ratio compared with homeostasis model assessment insulin resistance indexes in screening for metabolic syndrome in the Chinese obese children: a cross section study. BMC Pediatr. 2015;15:1–7.CrossRef Liang J, Fu J, Jiang Y, et al. Triglycerides and high-density lipoprotein cholesterol ratio compared with homeostasis model assessment insulin resistance indexes in screening for metabolic syndrome in the Chinese obese children: a cross section study. BMC Pediatr. 2015;15:1–7.CrossRef
19.
Zurück zum Zitat Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.CrossRef Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.CrossRef
20.
Zurück zum Zitat Di Meo S, Iossa S, Venditti P. Skeletal muscle insulin resistance: role of mitochondria and other ROS sources. J Endocrinology. 2017;233:15–42.CrossRef Di Meo S, Iossa S, Venditti P. Skeletal muscle insulin resistance: role of mitochondria and other ROS sources. J Endocrinology. 2017;233:15–42.CrossRef
21.
Zurück zum Zitat Bournat JC, Brown CW. Mitochondrial dysfunction in obesity. Curr Opin Endocrinol Diabetes Obes. 2010;17:446–52.CrossRef Bournat JC, Brown CW. Mitochondrial dysfunction in obesity. Curr Opin Endocrinol Diabetes Obes. 2010;17:446–52.CrossRef
22.
Zurück zum Zitat Berggren JR, Hulver MW, Dohm GL, et al. Weight loss and exercise: implications for muscle lipid metabolism and insulin action. Med Sci Sports Exerc. 2004;36:1191–5.CrossRef Berggren JR, Hulver MW, Dohm GL, et al. Weight loss and exercise: implications for muscle lipid metabolism and insulin action. Med Sci Sports Exerc. 2004;36:1191–5.CrossRef
23.
Zurück zum Zitat Noubiap JJ, Essouma M, Bigna JJ, et al. Prevalence of elevated blood pressure in children and adolescents in Africa: a systematic review and meta-analysis. Lancet. 2017;2:375–86. Noubiap JJ, Essouma M, Bigna JJ, et al. Prevalence of elevated blood pressure in children and adolescents in Africa: a systematic review and meta-analysis. Lancet. 2017;2:375–86.
24.
Zurück zum Zitat Petersen KF, Dufour S, Savage DB, et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A. 2007;104:12587–94.CrossRef Petersen KF, Dufour S, Savage DB, et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A. 2007;104:12587–94.CrossRef
25.
Zurück zum Zitat Mittendorfer B, Patterson BW, Klein S, et al. VLDL-triglyc-eride kinetics during hyperglycemia-hyperinsulinemia: effects ofsex and obesity. Am J Physiol Endocrinol Metab. 2003;284:708–15.CrossRef Mittendorfer B, Patterson BW, Klein S, et al. VLDL-triglyc-eride kinetics during hyperglycemia-hyperinsulinemia: effects ofsex and obesity. Am J Physiol Endocrinol Metab. 2003;284:708–15.CrossRef
26.
Zurück zum Zitat Ter Horst KW, Serlie MJ. Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease. Nutrients. 2017;9:981.CrossRef Ter Horst KW, Serlie MJ. Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease. Nutrients. 2017;9:981.CrossRef
27.
Zurück zum Zitat Haslam DE, Peloso GM, Herman MA, et al. Beverage consumption and longitudinal changes in lipoprotein concentrations and incident dyslipidemia in US adults: the Framingham heart study. J Am Heart Assoc. 2020;9:e014083.CrossRef Haslam DE, Peloso GM, Herman MA, et al. Beverage consumption and longitudinal changes in lipoprotein concentrations and incident dyslipidemia in US adults: the Framingham heart study. J Am Heart Assoc. 2020;9:e014083.CrossRef
28.
Zurück zum Zitat Softic S, Stanhope KL, Boucher J, et al. Fructose and hepatic insulin resistance. Crit Rev Clin Lab Sci. 2020;57:308–22.CrossRef Softic S, Stanhope KL, Boucher J, et al. Fructose and hepatic insulin resistance. Crit Rev Clin Lab Sci. 2020;57:308–22.CrossRef
29.
Zurück zum Zitat Imamura F, O’connor L, Ye Z, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ. 2015;351:h3576.CrossRef Imamura F, O’connor L, Ye Z, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ. 2015;351:h3576.CrossRef
30.
Zurück zum Zitat Stanhope KL. Sugar consumption, metabolic disease and obesity: the state of the controversy. Crit Rev Clin Lab Sci. 2016;53:52–67.CrossRef Stanhope KL. Sugar consumption, metabolic disease and obesity: the state of the controversy. Crit Rev Clin Lab Sci. 2016;53:52–67.CrossRef
31.
Zurück zum Zitat Schwarz JM, Noworolski SM, Wen MJ, et al. Effect of a high-fructose weight-maintaining diet onlipogenesis and liver fat. J Clin Endocrinol Metab. 2015;100:2434–42.CrossRef Schwarz JM, Noworolski SM, Wen MJ, et al. Effect of a high-fructose weight-maintaining diet onlipogenesis and liver fat. J Clin Endocrinol Metab. 2015;100:2434–42.CrossRef
32.
Zurück zum Zitat Lambert JE. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology. 2014;146:726–35.CrossRef Lambert JE. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology. 2014;146:726–35.CrossRef
33.
Zurück zum Zitat Nakajima K, Tanaka A. Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis. Clin Chim Acta. 2018;478:200–15.CrossRef Nakajima K, Tanaka A. Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis. Clin Chim Acta. 2018;478:200–15.CrossRef
34.
Zurück zum Zitat Sparks JD, Sparks CE, Adeli K. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2012;32:2104–12.CrossRef Sparks JD, Sparks CE, Adeli K. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2012;32:2104–12.CrossRef
35.
Zurück zum Zitat Rover MR, Kupek E, Delgado RC, et al. Lipid profile and its relationship with risk factors for atherosclerosis in children and adolescents. Rev Bras Anal Cln. 2010;42:191–5. Rover MR, Kupek E, Delgado RC, et al. Lipid profile and its relationship with risk factors for atherosclerosis in children and adolescents. Rev Bras Anal Cln. 2010;42:191–5.
36.
Zurück zum Zitat Tan HK, Yates E, Lilly K, et al. Oxidative stress in alcohol-related liver disease. World J Hepatol. 2020;12:332–49.CrossRef Tan HK, Yates E, Lilly K, et al. Oxidative stress in alcohol-related liver disease. World J Hepatol. 2020;12:332–49.CrossRef
37.
Zurück zum Zitat Aladin AI, Chevli PA, Ahmad MI, et al. Alcohol consumption and systemic hypertension (from the Third National Health and Nutrition Examination Survey). Am J Cardiol. 2021;160:60–6.CrossRef Aladin AI, Chevli PA, Ahmad MI, et al. Alcohol consumption and systemic hypertension (from the Third National Health and Nutrition Examination Survey). Am J Cardiol. 2021;160:60–6.CrossRef
38.
Zurück zum Zitat Valero-Elizondo J, Hong JC, Spatz ES, et al. Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: medical expenditure panel survey 2002–2013. Atherosclerosis. 2018;269:301–5.CrossRef Valero-Elizondo J, Hong JC, Spatz ES, et al. Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: medical expenditure panel survey 2002–2013. Atherosclerosis. 2018;269:301–5.CrossRef
39.
Zurück zum Zitat Williams J, et al. A systematic review of associations between non-communicable diseases and socioeconomic status within low-and lower-middle-income countries. J Glob Health. 2018;8:1–25.CrossRef Williams J, et al. A systematic review of associations between non-communicable diseases and socioeconomic status within low-and lower-middle-income countries. J Glob Health. 2018;8:1–25.CrossRef
40.
Zurück zum Zitat World Health Organization. Preventing chronic diseases—a vital investment: WHO global report. Geneva: World Health Organization; 2005. World Health Organization. Preventing chronic diseases—a vital investment: WHO global report. Geneva: World Health Organization; 2005.
41.
Zurück zum Zitat Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3:1–21.CrossRef Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3:1–21.CrossRef
42.
Zurück zum Zitat Arnold AP, Cassis LA, Eghbali M, et al. Sex hormones and sex chromosomes cause sex differences in the development of cardiovascular diseases. Arterioscler Thromb Vasc Biol. 2017;37:746–56.CrossRef Arnold AP, Cassis LA, Eghbali M, et al. Sex hormones and sex chromosomes cause sex differences in the development of cardiovascular diseases. Arterioscler Thromb Vasc Biol. 2017;37:746–56.CrossRef
Metadaten
Titel
Insulin resistance phenotype is associated with vascular risk phenotype at the end of the second decade of life: a population-based study
verfasst von
Janaina Maiana Abreu Barbosa
Antônio Augusto Moura da Silva
Rosangela Fernandes Lucena Batista
Bernadete Jorge Leal Salgado
Joelma Ximenes Prado Teixeira Nascimento
Vanda Maria Ferreira Simões
Maria Jacqueline Silva Ribeiro
Marco Antonio Barbieri
Alexandre Archanjo Ferraro
Cecilia Claudia Costa Ribeiro
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
Cardiovascular Diabetology / Ausgabe 1/2022
Elektronische ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-022-01724-0

Weitere Artikel der Ausgabe 1/2022

Cardiovascular Diabetology 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.